Tianeptine modulates synaptic vesicle dynamics and favors synaptic mitochondria processes in socially isolated rats

Sci Rep. 2021 Sep 7;11(1):17747. doi: 10.1038/s41598-021-97186-7.

Abstract

Deregulation of synaptic function and neurotransmission has been linked with the development of major depression disorder (MDD). Tianeptine (Tian) has been used as antidepressant with anxiolytic properties and recently as a nootropic to improve cognitive performance, but its mechanism of action is unknown. We conducted a proteomic study on the hippocampal synaptosomal fractions of adult male Wistar rats exposed to chronic social isolation (CSIS, 6 weeks), an animal model of depression and after chronic Tian treatment in controls (nootropic effect) and CSIS-exposed rats (lasting 3 weeks of 6-week CSIS) (therapeutic effect). Increased expression of Syn1 and Camk2-related neurotransmission, vesicle transport and energy processes in Tian-treated controls were found. CSIS led to upregulation of proteins associated with actin cytoskeleton, signaling transduction and glucose metabolism. In CSIS rats, Tian up-regulated proteins involved in mitochondrial energy production, mitochondrial transport and dynamics, antioxidative defense and glutamate clearance, while attenuating the CSIS-increased glycolytic pathway and cytoskeleton organization proteins expression and decreased the expression of proteins involved in V-ATPase and vesicle endocytosis. Our overall findings revealed that synaptic vesicle dynamics, specifically exocytosis, and mitochondria-related energy processes might be key biological pathways modulated by the effective nootropic and antidepressant treatment with Tian and be a potential target for therapeutic efficacy of the stress-related mood disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Anxiety Agents / pharmacology
  • Anti-Anxiety Agents / therapeutic use
  • Antidepressive Agents / pharmacology*
  • Antidepressive Agents / therapeutic use
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / physiopathology
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Gene Expression Regulation / drug effects
  • Hippocampus / drug effects
  • Hippocampus / ultrastructure
  • Male
  • Mitochondria / drug effects*
  • Mitochondria / physiology
  • Nerve Tissue Proteins / biosynthesis
  • Nerve Tissue Proteins / genetics
  • Nootropic Agents / pharmacology*
  • Nootropic Agents / therapeutic use
  • Protein Interaction Mapping
  • Proteome / drug effects*
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects
  • Social Isolation*
  • Synaptic Vesicles / drug effects*
  • Thiazepines / pharmacology*
  • Thiazepines / therapeutic use

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Nerve Tissue Proteins
  • Nootropic Agents
  • Proteome
  • Thiazepines
  • tianeptine